At a glance
ClinicalIndex Comparison RecordN/ACompleted· 103 enrolled
Drug / intervention
Predictive Low Glucose Suspenddevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Tandem PLGS Pivotal Trial: A Randomized Clinical Trial to Assess the Efficacy of Predictive Low Glucose Suspend Versus Sensor-augmented Pump Therapy in the Management of Type 1 Diabetes
In Brief
A clinical study evaluating Predictive Low Glucose Suspend for Diabetes Mellitus, Type 1. Completed, enrolled 103 participants across 4 sites.
Detailed Summary
A 6-week crossover study will compare PLGS to SAP outcomes in adults and youth \> 6 years old with type 1 diabetes (T1D).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Mellitus, Type 1
CountriesUnited States
CollaboratorsJaeb Center for Health Research
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
First PostedJun 2017
Enrollment StartAug 2017
Primary CompletionFeb 2018
TodayJul 2026
First PostedJun 22, 2017
Enrollment StartAug 11, 2017
Primary CompletionFeb 6, 2018
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 9.0 years ago
Interventions
Predictive Low Glucose Suspenddevice
Application of Predictive Low Glucose Suspend